Moors & Cabot’s AllianzIM U.S. Equity Buffer20 Feb ETF FEBW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$274K Sell
7,550
-100
-1% -$3.6K 0.01% 803
2026
Q2
$272K Sell
7,650
-500
-6% -$17.5K 0.01% 794
2026
Q1
$273K Buy
8,150
+2,250
+38% +$76.5K 0.01% 746
2025
Q4
$200K Buy
+5,900
New +$197K 0.01% 853
2025
Q3
– Sell
-6,900
Closed -$220K – 923
2025
Q2
$220K Sell
6,900
-1,700
-20% -$52.2K 0.01% 769
2025
Q1
$261K Buy
+8,600
New +$266K 0.01% 686
2024
Q4
– Sell
-6,900
Closed -$210K – 901
2024
Q3
$210K Hold
6,900
– – 0.01% 781
2024
Q2
$204K Buy
+6,900
New +$201K 0.01% 765

Other funds holding FEBW

Moors & Cabot's FEBW Position: Q3 2026 in Review

Moors & Cabot reduced its AllianzIM U.S. Equity Buffer20 Feb ETF (FEBW) stake by 1.3% in Q3 2026, selling an estimated $3.6K and leaving 7,550 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #803.

Moors & Cabot first reported a position in FEBW in Q2 2024 and has held it in 8 quarters since. 40 funds tracked by Wall St. Rank hold FEBW as of Q3 2026.

  • Moors & Cabot held 7,550 shares of AllianzIM U.S. Equity Buffer20 Feb ETF worth $274K as of Q3 2026.
  • Moors & Cabot sold 100 AllianzIM U.S. Equity Buffer20 Feb ETF shares in Q3 2026, an estimated $3.6K.
  • AllianzIM U.S. Equity Buffer20 Feb ETF made up 0.01% of Moors & Cabot's portfolio in Q3 2026, its #803 holding.
  • Moors & Cabot first reported a position in AllianzIM U.S. Equity Buffer20 Feb ETF in Q2 2024 and has held it in 8 quarters since.
  • 40 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Feb ETF as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.